Propanoic acid, 2-bromo-2-methyl-, ethyl ester → ethyl(+/-)-5-dodecyl-alpha,alpha-dimethyl-2H-tetrazole-2-acetate
Reaktionsgleichung
[CH2:1]([C:13]1[NH:17][N:16]=[N:15][N:14]=1)[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH2:11][CH3:12].C(C1NN=NN=1)CCCCCCCCC.[CH2:33]([O:35][C:36](=[O:41])[C:37](Br)([CH3:39])[CH3:38])[CH3:34].BrC1C=CC=CC=1CC(OCC)=O>>[CH2:1]([C:13]1[N:14]=[N:15][N:16]([C:37]([CH3:39])([CH3:38])[C:36]([O:35][CH2:33][CH3:34])=[O:41])[N:17]=1)[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH2:11][CH3:12]Komponenten
5
Versuchsvorschrift
When in the general procedure of Example 71 an appropriate amount of 5-dodecyl-1H-tetrazole was substituted for 5-decyl-1H-tetrazole and an appropriate amount of ethyl-2-bromoisobutyrate was substituted for ethyl 2-bromophenylacetate, the title compound was obtained.
Quellen und Nachweise
- ORD-Eintrag
- ord-aadaceb2ac214d119453726570a39ee9
- Quelldatensatz
- uspto-grants-1997_07
- Patentnummer
- US05646170
Notizen zur Reaktion
Wird geladen…